Streetbeat News

Products Services

DPZ

Domino's Pizza executive has stated that they expect Q3 same-store sales trends in their delivery business to be similar to Q2, indicating a challenging period. However, a slight improvement is expected in Q4 as the company begins to roll out its updated loyalty program.

Portfolio Pulse from Happy Mohamed

July 24, 2023 | 12:47 pm

PXMD

PaxMedica has released topline results from the PAX-101 (intravenous suramin) Phase 3 African Sleeping Sickness study, which has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 12:46 pm

AMC

PXMD

SNDX

AMC Entertainment's plan to convert preferred shares to common shares and implement a stock split was rejected by a court, causing its shares to trade higher. PaxMedica announced positive results from its Phase 3 study of PAX-101, and Syndax and Incyte announced positive results from their AGAVE-201 trial of Axatilimab.

Portfolio Pulse from ryanfaloona@benzinga.com

July 24, 2023 | 12:46 pm

DM

Desktop Health, a brand of Desktop Metal, Inc. (NYSE:DM), has announced the launch of PrintRoll, a rotating build platform for the 3D-Bioplotter. This innovative tool enables 3D printing of cylindrical medical solutions for various body channels. The PrintRoll platform further solidifies the 3D-Bioplotter's position in the field of bioprinting. The FDA recently granted 510(k) clearance to Dimension Inx for its CMFlex, a product developed and manufactured on the 3D-Bioplotter.

Portfolio Pulse from Happy Mohamed

July 24, 2023 | 12:45 pm

KOD

Kodiak Sciences has released topline results from three Phase 3 studies of tarcocimab tedromer for neovascular age-related macular degeneration and diabetic macular edema. Following the news, the company's shares are trading lower.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 12:40 pm

INDA

TSLA

Tesla executives are set to meet with India's Commerce Minister this month to discuss plans for a new factory to build a $24,000 car. The discussions will include setting up a supply chain and obtaining land for the factory.

Portfolio Pulse from Charles Gross

July 24, 2023 | 12:37 pm

NKLA

Shares of Nikola Corporation (NKLA) are trading lower after a Nikola truck that caught fire late last month reignited again on Sunday afternoon.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 12:37 pm

ABBV

AbbVie has announced that the first patient has been dosed in a global Phase 3 trial of Upadacitinib for Hidradenitis Suppurativa. This marks a significant step in the development of the drug.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 12:36 pm

ABBV

AbbVie has announced the first patient dosing in a global Phase 3 trial of upadacitinib for the treatment of moderate to severe hidradenitis suppurativa (HS), a chronic, inflammatory disease with limited therapeutic options. The trial, named Step-Up HS, is the first registered, randomized Phase 3 trial in HS and aims to enroll approximately 1,300 participants across 275 sites worldwide. The primary endpoint will measure the percentage of participants achieving a 50% reduction in the total abscess and inflammatory nodule count with no increase in abscess count and no increase in draining fistula count relative to baseline at week 16.

Portfolio Pulse from Happy Mohamed

July 24, 2023 | 12:33 pm

DYAI

Dyadic has completed dosing of patients for its recombinant protein RBD vaccine candidate, with no major safety concerns or serious adverse events reported. The vaccine produced an immune response at both dose levels. A full study report is expected in Q4, 2023.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 12:31 pm